Abbott MediaRoom - Press Releases

May 16, 2019
- Photos 1
New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results

- Abbott's ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient ("macros") ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat
- ZonePerfect Keto helps fulfill a keto lifestyle on the go - offering the only true keto ready-to-drink option available nationwide at major retailers
May 15, 2019
- Photos 1
Nearly 9 out of 10 College Students with Student Debt Say It's Important to Find a Company That Offers Loan Relief

- The YouGov-Abbott Student Loan Impact Survey shows 87% of those in college or graduating this year with student debt say finding a company with a student loan benefit is important to them
- Additionally, over 6 in 10 working adults with student loans would consider switching to a company with a student loan employee benefit
May 14, 2019
- Photos 1
Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders

- Partnership with NIH aims to increase understanding and accelerate the application of neurostimulation therapies
- The BRAIN Initiative brings together the brightest minds across disciplines to improve the treatment and prevention of brain disorders
May 7, 2019
- Photos 1
Abbott to Present at UBS Global Healthcare Conference
May 6, 2019
- Video 2
- Photos 6
Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats

WORLD'S FIRST SMARTPHONE-COMPATIBLE IMPLANTABLE HEART MONITOR, ABBOTT'S CONFIRM Rx™ ICM OFFERS MORE ACCURATE DETECTION OF HEART RHYTHM DISORDERS

Show per page

true

accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

yes no

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

yes no

accessibility

Asset Warning

yes no

PRESS RELEASES

You are about to exit for another Abbott country or region specific website

Do you wish to continue and exit this website?

You are about to exit the Abbott family of websites for a 3rd party website

Do you wish to continue and exit this website?